A very recent study from Bai et al, 2019 [59], showed that hyperlipidemic drug-simvastatin reduces cell proliferation and induces apoptosis in breast cancer cells by up-regulating miR-140-5p via activation of the transcription factor NRF1. The gene discussed is NRF1; the disease is breast carcinoma.